Navigation Links
New book covers 16 years of MSU research in Yellowstone
Date:10/20/2008

BOZEMAN, Mont. -- A multitude of findings about life in the heart of Yellowstone National Park are described in a new book covering 16 years of Montana State University research.

The book titled "The Ecology of Large Mammals in Central Yellowstone: Sixteen Years of Integrated Field Studies" covers many of the large charismatic animals that receive national and international attention, said editor and MSU ecologist Robert A. Garrott. It also deals with ecological processes that interest the general public, scientists, policy makers and park managers.

Wolves were reintroduced halfway through the study, so the researchers were able to document their effect on the behavior and population dynamics of elk and bison, Garrott said. As the park's winter recreation policy became controversial, the scientists also became involved in studying wildlife responses to snowmobiles and snowcoaches and the potential effects of grooming the roads in winter on bison migration and movement patterns.

The purpose of the book is to provide readers a synthesis of a diverse body of research, Garrott said. He added that the effort was unique in its length and breadth.

Initial chapters describe characteristics of the landscape, climate, precipitation and snow pack dynamics. The core of the book presents several studies on elk, bison and wolf ecology and the interactions among them. The authors conclude with an introspective discussion of the strengths and limitations of science to contribute to the contentious debates about wildlife and natural resource management in Yellowstone.

"My hope is that lots of people can pick up the book and understand everything we did, what we learned, what we didn't learn, the surprises and the uncertainties about where the system is going in the future," Garrott said. "The themes are ecological processes that are pervasive in all ecosystems and communities throughout the world."

Garrott edited the book w
'/>"/>

Contact: Evelyn Boswell
evelynb@montana.edu
406-994-5135
Montana State University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Computational biochemist uncovers a molecular clue to evolution
2. University of Miami scientist uncovers miscalculation in geological undersea record
3. UCR graduate student discovers, names bacterium linked to psyllid yellows
4. Wildlife Conservation Society discovers Planet of the Apes
5. N.Y. research team discovers how antidepressants and cocaine interact with brain cell targets
6. U of T discovers environmental factors linked to sex ratio of plants
7. Expanded histology methods book covers processing of animal, plant, and microbial tissues
8. Epigenetic research uncovers new targets for modification enzymes
9. AMNH scientists grace Science & Nature covers
10. NYU dental professor discovers biological clock linking tooth growth to other metabolic processes
11. Researcher discovers pathway plants use to fight back against pathogens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 Increasing ... technological advancement to drive biometric systems market in ...   According to a recently released ... &  Opportunities, 2020 ", biometric systems market in ... growth at CAGR of over 22% through 2020. ...
(Date:4/14/2015)... OXFORD, Conn. , April 14, 2015 ... "Company"), a biometric authentication company focused on the growing ... has been nominated for the 2015 New York Design ... The Design100, New York City Design Awards are ... are based on over 2,500 ratings from the marketplace, ...
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... virus discovered last year in a rare form of skin ... most common form of skin cancer among Americans, according to ... James Cancer Hospital and Solove Research Institute. The researchers examined ... a highly curable form of skin cancer that is expected ...
... A team of 80 researchers from more than ... Environmental and Cultural Change in Maryland,s Coastal Bays, a ... making up Maryland,s Atlantic coastline. Published by IAN ... setting, context and ecology of these waterways, their islands ...
... adults who have less strength, poor physical function and low muscle ... with more strength and better function. That,s the finding of a ... . The study also found that muscle density, a measure ... the muscle, is a more accurate gauge of a person,s risk ...
Cached Biology News:Study links virus to some cases of common skin cancer 2Reducing risk of hospitalization in the elderly 2
(Date:6/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lkcspr/2015_strategies ... "2015 Strategies in European Immunoprotein Diagnostic ... This new 273-page report provides ... including emerging tests, technologies, instrumentation, sales forecasts, ... suppliers. Companies Mentioned: - ...
(Date:6/1/2015)... June 1, 2015  OncoSec Medical Inc. ("OncoSec") ... intratumoral cancer immunotherapies, today announced a collaboration with ... Veterinary Medicine to test ImmunoPulse™ IL-12 as an ... primary goals of the canine study are to ... of ImmunoPulse™ IL-12 and validate key clinical biomarkers. ...
(Date:6/1/2015)... Hutchison China MediTech Limited ... (publ) ("AstraZeneca"), Hutchison MediPharma Limited,s ("HMP") collaboration partner, ... clinical trial of HMP,s c-Met inhibitor savolitinib (AZD6094) ... cell lung cancer ("NSCLC"). AZD9291 is ... receptor (EGFR). Preliminary data on the activity of ...
(Date:5/31/2015)... 31, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... oncology and drug-delivery therapies, today announced interim findings ... its investigational new drug PEGPH20 for the potential ... The encouraging interim data was presented today ... meeting in an oral presentation by Principal Investigator ...
Breaking Biology Technology:OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma 2OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma 3OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma 4Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 2Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 3Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 4Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 5
... AMGN ) Senior Vice President of Research and ... U.S. Food and Drug Administration (FDA) panel charged with implementing ... patient safety and follow a science-based approach. "Put ... "Amgen believes biosimilars have a meaningful role to play in ...
... November 1, 2010 ... ... --> ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r in ...
... Influenza Vaccine ... ... ... Results are keyed by longUrl, so we need to grab the first one. for (var r in data.results) { ...
Cached Biology Technology:Amgen to Provide Testimony at FDA Hearing on Biosimilars 2Amgen to Provide Testimony at FDA Hearing on Biosimilars 3Amgen to Provide Testimony at FDA Hearing on Biosimilars 4Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation 2Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation 3Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation 4Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation 5Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation 6Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation 7Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation 8Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation 9Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine 2Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine 3Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine 4Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine 5Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine 6Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine 7Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine 8
Nestin, Human...
Ezrin/Radixin/Moesin Antibody...
... Taura Syndrome Virus Coat Protein ... tested applications). ... MNDIPITNQN VVLSKNVTDN LFEVQDQALI ESLSRDVLLH NDSWTSSDDE ... terminal amino acids 25/100 of ...
JAB1 Immunogen: Synthetic peptide, conjugated to KLH, corresponding to residues S(201) E Y Q T I P L N K I E D F G V(216) of human JAB1. The sequence is identical in mouse and rat. Storage: -...
Biology Products: